M. Esteller, Epigenetics in Cancer, New England Journal of Medicine, vol.358, issue.11, pp.1148-59, 2008.
DOI : 10.1056/NEJMra072067

A. Eden, F. Gaudet, A. Waghmare, and R. Jaenisch, Chromosomal Instability and Tumors Promoted by DNA Hypomethylation, Science, vol.300, issue.5618, p.455, 2003.
DOI : 10.1126/science.1083557

E. Hervouet, E. Debien, M. Cheray, P. Hulin, D. Loussouarn et al., Disruption of Dnmt1/PCNA/UHRF1 Interactions Promotes Tumorigenesis from Human and Mice Glial Cells, PLoS ONE, vol.23, issue.6, p.11333, 2010.
DOI : 10.1371/journal.pone.0011333.s014

E. Toraño, S. Petrus, A. Fernandez, and M. Fraga, Global DNA hypomethylation in cancer: review of validated methods and clinical significance, Clinical Chemistry and Laboratory Medicine, vol.50, issue.10, pp.1733-1775, 2012.
DOI : 10.1515/cclm-2011-0902

S. Fukushige and A. Horii, DNA Methylation in Cancer: A Gene Silencing Mechanism and the Clinical Potential of Its Biomarkers, The Tohoku Journal of Experimental Medicine, vol.229, issue.3, pp.173-85, 2013.
DOI : 10.1620/tjem.229.173

F. Chik and M. Szyf, Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors, Carcinogenesis, vol.32, issue.2, pp.224-256, 2011.
DOI : 10.1093/carcin/bgq221

M. Cheray, R. Pacaud, A. Nadaradjane, F. Vallette, and P. Cartron, Specific inhibition of one DNMT1-including complex influences tumor initiation and progression, Clinical Epigenetics, vol.5, issue.1, p.9, 2013.
DOI : 10.1016/j.toxlet.2011.12.020

URL : https://hal.archives-ouvertes.fr/inserm-00851207

M. Cheray, A. Nadaradjane, P. Bonnet, S. Routier, F. Vallette et al., Specific inhibition of DNMT1/CFP1 reduces cancer phenotypes and enhances chemotherapy effectiveness, Epigenomics, vol.6, issue.3
DOI : 10.2217/epi.14.18

J. Issa, Optimizing therapy with methylation inhibitors in myelodysplastic syndromes: dose, duration, and patient selection, Nature Clinical Practice Oncology, vol.22, pp.24-33, 2005.
DOI : 10.1038/ncponc0355

R. Amato, J. Stephenson, S. Hotte, J. Nemunaitis, K. Bélanger et al., MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma, Cancer Investigation, vol.63, issue.16, pp.415-436, 2012.
DOI : 10.1016/S0163-7258(97)00108-3

D. Kuck, N. Singh, F. Lyko, and J. Medina-franco, Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation, Bioorganic & Medicinal Chemistry, vol.18, issue.2, pp.822-831, 2010.
DOI : 10.1016/j.bmc.2009.11.050

D. Kuck, T. Caulfield, F. Lyko, and J. Medina-franco, Nanaomycin A Selectively Inhibits DNMT3B and Reactivates Silenced Tumor Suppressor Genes in Human Cancer Cells, Molecular Cancer Therapeutics, vol.9, issue.11, pp.3015-3038, 2010.
DOI : 10.1158/1535-7163.MCT-10-0609

B. Lee, S. Yegnasubramanian, X. Lin, and W. Nelson, Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1, Journal of Biological Chemistry, vol.280, issue.49, pp.40749-56, 2005.
DOI : 10.1074/jbc.M505593200

A. Rajavelu, Z. Tulyasheva, R. Jaiswal, A. Jeltsch, and N. Kuhnert, The inhibition of the mammalian DNA methyltransferase 3a (Dnmt3a) by dietary black tea and coffee polyphenols, BMC Biochem, vol.21, pp.12-18, 2011.

J. Medina-franco, F. López-vallejo, D. Kuck, and F. Lyko, Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach, Molecular Diversity, vol.16, issue.2, pp.293-304, 2011.
DOI : 10.1007/s11030-010-9262-5

T. Suzuki, R. Tanaka, S. Hamada, H. Nakagawa, and N. Miyata, Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors, Bioorganic & Medicinal Chemistry Letters, vol.20, issue.3, pp.1124-1131, 2010.
DOI : 10.1016/j.bmcl.2009.12.016

J. Yoo, J. Kim, K. Robertson, and J. Medina-franco, Molecular Modeling of Inhibitors of Human DNA Methyltransferase with a Crystal Structure, Adv Protein Chem Struct Biol, vol.87, pp.219-266, 2012.
DOI : 10.1016/B978-0-12-398312-1.00008-1

J. Yoo and J. Medina-franco, Inhibitors of DNA Methyltransferases: Insights from Computational Studies, Current Medicinal Chemistry, vol.19, issue.21, pp.3475-87, 2012.
DOI : 10.2174/092986712801323289

M. Venza, M. Visalli, T. Catalano, C. Fortunato, R. Oteri et al., Impact of DNA methyltransferases on the epigenetic regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor expression in malignant melanoma, Biochemical and Biophysical Research Communications, vol.441, issue.4, pp.743-50, 2013.
DOI : 10.1016/j.bbrc.2013.10.114

V. Van-beusechem, J. Grill, D. Mastenbroek, T. Wickham, P. Roelvink et al., Efficient and Selective Gene Transfer into Primary Human Brain Tumors by Using Single-Chain Antibody-Targeted Adenoviral Vectors with Native Tropism Abolished, Journal of Virology, vol.76, issue.6, pp.2753-62, 2002.
DOI : 10.1128/JVI.76.6.2753-2762.2002

L. Schaefer, D. Schuster, and J. Schaffer, Structured illumination microscopy: artefact analysis and reduction utilizing a parameter optimization approach, Journal of Microscopy, vol.216, issue.2, pp.165-74, 2004.
DOI : 10.1111/j.0022-2720.2004.01411.x

F. Fuks, W. Burgers, N. Godin, M. Kasai, and T. Kouzarides, Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription, The EMBO Journal, vol.20, issue.10, pp.2536-2580, 2001.
DOI : 10.1093/emboj/20.10.2536

E. Hervouet, F. Vallette, and P. Cartron, Dnmt3/transcription factor interactions as crucial players in targeted DNA methylation, Epigenetics, vol.4, issue.7, 2009.
DOI : 10.4161/epi.4.7.9883

D. Louis, H. Ohgaki, O. Wiestler, W. Cavenee, P. Burger et al., The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007.
DOI : 10.1007/s00401-007-0243-4

M. Esteller, J. Garcia-foncillas, E. Andion, S. Goodman, O. Hidalgo et al., and the Clinical Response of Gliomas to Alkylating Agents, New England Journal of Medicine, vol.343, issue.19, pp.1350-1354, 2000.
DOI : 10.1056/NEJM200011093431901

M. Hegi, A. Diserens, T. Gorlia, M. Hamou, N. De-tribolet et al., MGMT gene silencing and benefit from temozolomide in glioblastoma, N Engl J Med, vol.352, pp.991-1003, 2005.

J. Foulks, K. Parnell, R. Nix, S. Chau, K. Swierczek et al., Epigenetic Drug Discovery, Journal of Biomolecular Screening, vol.9, issue.1, pp.2-17, 2012.
DOI : 10.1016/S1470-2045(09)70003-8

J. Fahy, A. Jeltsch, and P. Arimondo, DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies, Expert Opinion on Therapeutic Patents, vol.71, issue.4, pp.1427-1469, 2012.
DOI : 10.1126/science.1214453

K. Li, F. Li, Q. Li, K. Yang, and J. B. , DNA Methylation as a Target of Epigenetic Therapeutics in Cancer, Anti-Cancer Agents in Medicinal Chemistry, vol.13, issue.2, pp.242-249, 2013.
DOI : 10.2174/1871520611313020009

J. Medina-franco and J. Yoo, Molecular Modeling and Virtual Screening of DNA Methyltransferase Inhibitors, Current Pharmaceutical Design, vol.19, issue.12, pp.2138-2185, 2013.
DOI : 10.2174/1381612811319120002

P. Cartron, P. Juin, L. Oliver, S. Martin, K. Meflah et al., Nonredundant Role of Bax and Bak in Bid-Mediated Apoptosis, Molecular and Cellular Biology, vol.23, issue.13, pp.4701-4713, 2003.
DOI : 10.1128/MCB.23.13.4701-4712.2003

E. Hervouet, E. Debien, J. Charbord, J. Menanteau, F. Vallette et al., Folate Supplementation Limits the Aggressiveness of Glioma via the Remethylation of DNA Repeats Element and Genes Governing Apoptosis and Proliferation, Clinical Cancer Research, vol.15, issue.10, pp.3519-3548, 2009.
DOI : 10.1158/1078-0432.CCR-08-2062

R. Zukiel, S. Nowak, A. Barciszewska, I. Gawronska, G. Keith et al., A simple epigenetic method for the diagnosis and classification of brain tumors, Mol Cancer Res, vol.2, pp.196-202, 2004.

J. Medina-franco and T. Caulfield, Advances in the computational development of DNA methyltransferase inhibitors, Drug Discovery Today, vol.16, issue.9-10, pp.418-443, 2011.
DOI : 10.1016/j.drudis.2011.02.003

C. Gros, J. Fahy, L. Halby, I. Dufau, A. Erdmann et al., DNA methylation inhibitors in cancer: Recent and future approaches, Biochimie, vol.94, issue.11, pp.2280-96, 2012.
DOI : 10.1016/j.biochi.2012.07.025